ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
Testosterone Treatment Does Not Increase Aggression in Transgender People
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="Nelson Vergel" data-source="post: 126435" data-attributes="member: 3"><p><em>Endocrine Abstracts</em> (2018) <strong>57</strong> 013</p><p><span style="font-size: 22px"><strong>No correlation between serum testosterone levels and aggression or anger intensity in transgender people: Results from five European Centres</strong></span></p><p></p><p><span style="font-size: 18px"><strong>J Defreyne1, J Arcelus2,3, W Bouman2, N Brewin2, E Elaut4, B Kreukels5,6, G Heylens4, M Den Heijer5,6 & G T’Sjoen1,4</strong></span></p><p></p><p>Aim: Anger is a state of emotions ranging from irritation to intense rage. Aggression is the externalization of anger through destructive/punitive behavior. The World Professional Association for Transgender Health (WPATH) Standards of Care, Edition 7 (SOC7) guidelines warn about aggression in transgender men (TM) on testosterone treatment. We aimed to assess whether aggression and anger intensity increase in TM and decrease in transgender women (TW) after initiation of gender affirming hormone therapy and to identify predictors for anger intensity in transgender people, including levels of sex steroids as well as psychological measurements.</p><p></p><p>Method: This work is a collaboration between the Nottingham Centre for Transgender Health, who assessed aggression, and the European Network for the Investigation of Gender Incongruence (ENIGI), who assessed anger intensity. Prospective changes in aggression were measured at baseline and after one year of gender affirming hormones in 155 transgender persons (64 TM, 91 TW), using the Inventory of Interpersonal Problems (IIP-32) factor ‘too aggressive’. Anger intensity was prospectively assessed in 898 participants (440 TM, 468 TW) by the STAXI-2 (State-Trait Anger Expression Inventory-2) State Anger (S-Anger) questionnaire during a three-year follow-up period, starting at the initiation of hormone treatment (testosterone in TM, oestrogens plus anti-androgens in TW). At baseline, psychological questionnaires were administered. Data were analysed cross-sectionally and prospectively.</p><p></p><p>Results: No prospective changes were reported in ‘too aggressive’ scores (after one year of hormone therapy) and S-Anger scores (over 3, 12 and 36 months of hormone therapy) in TM and TW. ‘Too aggressive’ scores were positively correlated to increasing anxiety scores in the entire study population and with lower support from friends in TW. At three, twelve and thirty-six months of gender affirming hormone therapy, anger intensity was not correlated to serum testosterone levels, although there was a correlation with various psychological measures after three and twelve months. TM experiencing menstrual spotting after three months had higher S-Anger scores compared to those without (median 26.5 [18.0 – 29.8] versus 15.0 [15.0 – 17.0], <em>P</em>=0.020). Changes in STAXI-2 S-Anger scores were not correlated to changes in serum testosterone levels after three, twelve and thirty-six months in TM or TW.</p><p></p><p>Conclusion: Aggression and anger intensity are associated with psychological and/or psychiatric vulnerability or the persistence of menstruation in TM, but not with exogenous testosterone therapy in TM or serum testosterone levels in both TM and TW.</p></blockquote><p></p>
[QUOTE="Nelson Vergel, post: 126435, member: 3"] [I]Endocrine Abstracts[/I] (2018) [B]57[/B] 013 [SIZE=22px][B]No correlation between serum testosterone levels and aggression or anger intensity in transgender people: Results from five European Centres[/B][/SIZE] [SIZE=18px][B]J Defreyne1, J Arcelus2,3, W Bouman2, N Brewin2, E Elaut4, B Kreukels5,6, G Heylens4, M Den Heijer5,6 & G T’Sjoen1,4[/B][/SIZE] Aim: Anger is a state of emotions ranging from irritation to intense rage. Aggression is the externalization of anger through destructive/punitive behavior. The World Professional Association for Transgender Health (WPATH) Standards of Care, Edition 7 (SOC7) guidelines warn about aggression in transgender men (TM) on testosterone treatment. We aimed to assess whether aggression and anger intensity increase in TM and decrease in transgender women (TW) after initiation of gender affirming hormone therapy and to identify predictors for anger intensity in transgender people, including levels of sex steroids as well as psychological measurements. Method: This work is a collaboration between the Nottingham Centre for Transgender Health, who assessed aggression, and the European Network for the Investigation of Gender Incongruence (ENIGI), who assessed anger intensity. Prospective changes in aggression were measured at baseline and after one year of gender affirming hormones in 155 transgender persons (64 TM, 91 TW), using the Inventory of Interpersonal Problems (IIP-32) factor ‘too aggressive’. Anger intensity was prospectively assessed in 898 participants (440 TM, 468 TW) by the STAXI-2 (State-Trait Anger Expression Inventory-2) State Anger (S-Anger) questionnaire during a three-year follow-up period, starting at the initiation of hormone treatment (testosterone in TM, oestrogens plus anti-androgens in TW). At baseline, psychological questionnaires were administered. Data were analysed cross-sectionally and prospectively. Results: No prospective changes were reported in ‘too aggressive’ scores (after one year of hormone therapy) and S-Anger scores (over 3, 12 and 36 months of hormone therapy) in TM and TW. ‘Too aggressive’ scores were positively correlated to increasing anxiety scores in the entire study population and with lower support from friends in TW. At three, twelve and thirty-six months of gender affirming hormone therapy, anger intensity was not correlated to serum testosterone levels, although there was a correlation with various psychological measures after three and twelve months. TM experiencing menstrual spotting after three months had higher S-Anger scores compared to those without (median 26.5 [18.0 – 29.8] versus 15.0 [15.0 – 17.0], [I]P[/I]=0.020). Changes in STAXI-2 S-Anger scores were not correlated to changes in serum testosterone levels after three, twelve and thirty-six months in TM or TW. Conclusion: Aggression and anger intensity are associated with psychological and/or psychiatric vulnerability or the persistence of menstruation in TM, but not with exogenous testosterone therapy in TM or serum testosterone levels in both TM and TW. [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
Testosterone Treatment Does Not Increase Aggression in Transgender People
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top